Cargando…
AMCP Partnership Forum: What’s Next for Specialty Medication Benefit Design and Reimbursement
Rising specialty drug costs present a challenge for patients and payers. High-cost products, such as gene therapies or immunotherapies, can significantly affect the budget of a payer that does not have the ability to spread risk across a large population. Stakeholders are considering new reimburseme...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391050/ https://www.ncbi.nlm.nih.gov/pubmed/32780612 http://dx.doi.org/10.18553/jmcp.2020.20121 |